Ionis Pharmaceuticals IONS Proceeds From Real Estate Transaction
Discontinued — last reported Q4 '25
Proceeds From Real Estate Transaction at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:ProceedsFromRealEstateTransaction.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's proceeds from real estate transaction.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's proceeds from real estate transaction?
- Ionis Pharmaceuticals (IONS) reported proceeds from real estate transaction of $0 in Q4 2025.
- What does proceeds from real estate transaction mean?
- Cash received from selling real estate assets.
- How do you interpret proceeds from real estate transaction?
- An increase suggests asset liquidation to improve liquidity or optimize the physical footprint.
- How does proceeds from real estate transaction compare across companies?
- Occasional non-recurring cash inflow seen across various capital-intensive industries.